Holen Sie sich die Stockscreener-App
0.43
0.00%
0.00
Promis Neurosciences Inc Aktie (PMN) Neueste Nachrichten
Is ProMIS Neurosciences Inc. stock entering bullish territoryQuarterly Portfolio Report & Verified High Yield Trade Plans - Newser
Applying Wyckoff theory to ProMIS Neurosciences Inc. stockWeekly Market Summary & Free Expert Verified Stock Movement Alerts - Newser
Using economic indicators to assess ProMIS Neurosciences Inc. potentialFed Meeting & Proven Capital Preservation Methods - Newser
Technical analysis overview for ProMIS Neurosciences Inc. stockWeekly Profit Recap & Verified High Yield Trade Plans - Newser
What’s the recovery path for long term holders of ProMIS Neurosciences Inc. - Newser
Market reaction to ProMIS Neurosciences Inc.’s recent newsMarket Activity Recap & Community Verified Watchlist Alerts - Newser
ProMIS Neurosciences stock price surges in pre market trading as company receives FDA fast track designation for alzheimer’s drug candidate PMN310 - MSN
ProMIS Neurosciences Reports Increased R&D Expenses and Net Loss - MSN
Promis Neurosciences (NASDAQ:PMN) and Beam Therapeutics (NASDAQ:BEAM) Critical Survey - Defense World
ProMIS Neurosciences files to sell 28.23M common shares for holders - MSN
ProMIS Neurosciences Plunges 11.63% on SEC Filing - AInvest
Smart tools for monitoring ProMIS Neurosciences Inc.’s price actionSwing Trade & Real-Time Volume Triggers - Newser
ProMIS Neurosciences Inc. stock trend outlook and recovery pathTreasury Yields & Fast Moving Stock Trade Plans - Newser
ProMIS Neurosciences' Secondary Equity Offering: Strategic Motivations and Market Implications - AInvest
ProMIS Neurosciences Inc. stock trend forecastPortfolio Value Report & Low Drawdown Investment Strategies - Newser
What MACD signals say about ProMIS Neurosciences Inc.Quarterly Profit Report & Growth Focused Entry Reports - Newser
ProMIS Neurosciences (PMN) Files Prospectus for Sale of 28.23M S - GuruFocus
ProMIS Neurosciences files prospectus of 28.2 mln common shares offering relates to resale by selling securityholders - MarketScreener
ProMIS Neurosciences' Share Offering and Its Implications for Shareholder Value and Market Perception - AInvest
Does ProMIS Neurosciences Inc. have a sustainable dividend2025 Year in Review & AI Enhanced Market Trend Forecasts - خودرو بانک
Has ProMIS Neurosciences Inc. formed a bullish divergenceWeekly Profit Recap & Pattern Based Trade Signal System - Newser
ProMIS Neurosciences shares fall 7.88% premarket despite positive trial updates and approvals. - AInvest
Will ProMIS Neurosciences Inc. see short term momentumEarnings Beat & Daily Technical Stock Forecast Reports - Newser
Using data tools to time your ProMIS Neurosciences Inc. exitMarket Growth Report & Technical Entry and Exit Alerts - Newser
Sector ETF performance correlation with ProMIS Neurosciences Inc.Risk Management & Consistent Profit Alerts - Newser
Why ProMIS Neurosciences Inc. is moving todayEarnings Overview Summary & Weekly Top Stock Performers List - Newser
ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310 - Ariva
Live market analysis of ProMIS Neurosciences Inc.July 2025 Closing Moves & Weekly Top Gainers Alerts - Newser
ProMIS Neurosciences' PMN310: A Safer, Differentiated Alzheimer’s Therapy with Strong Clinical and Regulatory Momentum - AInvest
ProMIS Neurosciences Gets Approval to Advance Alzheimer's Disease Treatment to Final Dose Escalation - MarketScreener
ProMIS Neurosciences advances Alzheimer's trial to final dose escalation cohort. - AInvest
ProMIS Neurosciences Receives DSMB Approval to Advance to - GlobeNewswire
ProMIS Neurosciences Receives DSMB Approval for PMN310 Alzheimer's Trial to Advance to Final Dose Cohort. - AInvest
Zero ARIA Cases: ProMIS's Novel Alzheimer's Drug PMN310 Advances to Final Trial Phase with Clean Safety Data - Stock Titan
Ranking ProMIS Neurosciences Inc. among high performing stocks via toolsWeekly Risk Summary & Weekly Momentum Picks - Newser
What indicators show strength in ProMIS Neurosciences Inc.Weekly Stock Report & Short-Term High Return Ideas - Newser
Relative strength of ProMIS Neurosciences Inc. in sector analysisWeekly Market Report & AI Forecasted Entry/Exit Points - Newser
ProMIS Neurosciences Inc. stock outlook for YEARJuly 2025 Update & Real-Time Chart Pattern Alerts - Newser
Visualizing ProMIS Neurosciences Inc. stock with heatmaps2025 Technical Overview & Smart Investment Allocation Tips - Newser
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):